Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement

Nephrol Dial Transplant. 2013 Jun;28(6):1346-59. doi: 10.1093/ndt/gft033. Epub 2013 Apr 12.


Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) group has produced comprehensive clinical practice guidelines for the management of anaemia in CKD patients. These guidelines addressed all of the important points related to anaemia management in CKD patients, including therapy with erythropoieis stimulating agents (ESA), iron therapy, ESA resistance and blood transfusion use. Because most guidelines were 'soft' rather than 'strong', and because global guidelines need to be adapted and implemented into the regional context where they are used, on behalf of the European Renal Best Practice Advisory Board some of its members, and other external experts in this field, who were not participants in the KDIGO guidelines group, were invited to participate in this anaemia working group to examine and comment on the KDIGO documents in this position paper. In this article, the group concentrated only on those guidelines which we considered worth amending or adapting. All guidelines not specifically mentioned are fully endorsed.

Keywords: anaemia; chronic kidney disease; erythropoiesis stimulating agents; iron; mortality.

MeSH terms

  • Anemia / etiology
  • Anemia / therapy*
  • Disease Management
  • Europe
  • Humans
  • Practice Guidelines as Topic / standards*
  • Renal Insufficiency, Chronic / complications*